C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
G4C2 hexanucleotide repeat expansions in the first intron of C9ORF72 are the most common cause of familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (collectively, C9ALS/FTD) [4, 6, 11, 14]. Haploinsufficiency (loss-of-function) of C9ORF72 protein is a key proposed disease mechanism which may act in parallel with gain-of-function mechanisms, including toxic RNAs from repeat transcription and dipeptide repeat proteins (DPRs) from repeat-associated non-AUG (RAN) translation [5, 9, 17]. However, the effect of C9orf72 deficiency in the background of gain-of-function has not been examined in vivo. Neither heterozygous nor homozygous knockout (KO) of C9orf72 in neurons leads to motor deficits in mice [8]. Recently, gain-of-function mouse models were generated using a C9ORF72 bacterial artificial chromosome (BAC) from C9ALS/FTD patient DNA under the control of the endogenous regulatory elements. Interestingly, three out of four of these C9-BAC transgenic mice did not develop motor behavior deficits, even at advanced ages [7, 12, 13]. Since these C9-BAC mouse models contain elevated C9orf72 proteins from the endogenous mouse gene, we hypothesized that C9orf72 provides neuroprotective effects against motor deficits in C9-BAC mice. To test this hypothesis and investigate the in vivo significance of C9orf72 haploinsufficiency, we crossed C9orf72 mice with C9-BAC mice and examined the consequences of C9orf72 protein dose reduction (loss-of-function) in the background of C9-BAC (gain-of-function). We found that C9orf72 loss and haploinsufficiency exacerbate motor behavior deficits in a dose-dependent manner, and this occurs early in the course of pathogenesis (4 months of age). Among the four published C9-BAC mouse models, we selected the one with motor deficits (we refer to this C9orf72 BAC + model as the C9-BAC line here) [10]. To reduce C9orf72 protein levels at different doses, we crossed C9orf72 and C9-BAC mice for two generations. We isolated proteins from brain tissues and confirmed the expected C9orf72 protein dose reduction (Fig. 1a, Additional file 1: Figure S1A). The unchanged protein level of Atg101, which is associated with the C9orf72/Smcr8 complex based on our previous study [16], suggests the specificity of C9orf72 reduction (Fig. 1a, Additional file 1: Figure S1A). To study effects of C9orf72 deficiency on the motor behaviors of C9-BAC mice, we monitored a cohort of mice [20 WT (10 females + 10 males), 18 C9-BAC (11 females + 7 males), 26 C9orf72;C9-BAC (14 females + 12 males), and 19 C9orf72;C9-BAC (10 females + 9 males)]. We excluded C9orf72 and C9orf72 mice for the following reasons: C9orf72 heterozygous and homozygous KO mice exhibited no neurodegeneration and motor deficits based on previous studies [8]; complete deletion of C9orf72, which does not occur in C9ALS/FTD patients, led to autoimmune disorders and reduced survival in mice [1], which may complicate large-scale behavior and survival studies. We found that there were no significant differences among the four tested groups in their survival around 4months, when behaviors were assessed. They also exhibited similar body weights, taking the sex of the mice into account (Additional file 1: Figure S1B-1C). To examine their general anxiety levels, we performed an open field test [3]. C9-BAC mice with different C9orf72 levels behaved similarly in total distance traveled, * Correspondence: jianfu@usc.edu Qiang Shao and Chen Liang contributed equally to this work. Center for Craniofacial Molecular Biology, University of Southern California (USC), Los Angeles, CA 90033, USA
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811
Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., Chiò, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70043-1 · Cited by 1,210
Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons
Shi, Y., Lin, S., Staats, K. A., Li, Y., Chang, W.-H., Hung, S.-T., Hendricks, E., Linares, G. R., Wang, Y., Son, E. Y., et al. (2018) · Nature Medicine · doi:10.1038/nm.4490 · Cited by 566
Self-citationJiang, J., Zhu, Q., Gendron, T. F., Saberi, S., McAlonis-Downes, M., Seelman, A., Stauffer, J. E., Jafar-nejad, P., Drenner, K., Schulte, D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.006 · Cited by 536
C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD
O’Rourke, J. G., Bogdanik, L., Muhammad, A. K. M. G., Gendron, T. F., Kim, K. J., Austin, A., Cady, J., Liu, E. Y., Zarrow, J., Grant, S., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.10.027 · Cited by 298
Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease
Burberry, A., Suzuki, N., Wang, J.-Y., Moccia, R., Mordes, D. A., Stewart, M. H., Suzuki-Uematsu, S., Ghosh, S., Singh, A., Merkle, F. T., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6038 · Cited by 269
A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy
Yang, M., Liang, C., Swaminathan, K., Herrlinger, S., Lai, F., Shiekhattar, R., & Chen, J.-F. (2016) · Science Advances · doi:10.1126/sciadv.1601167 · Cited by 238
Self-citation
Cited by
Molecular mechanisms underlying nucleotide repeat expansion disorders
Malik, I., Kelley, C. P., Wang, E. T., & Todd, P. K. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00382-6 · Cited by 363
ALS Genetics: Gains, Losses, and Implications for Future Therapies
Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R., & Gitler, A. D. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.022 · Cited by 370
The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia
Abramzon, Y. A., Fratta, P., Traynor, B. J., & Chia, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00042 · Cited by 244
“These include (Cleveland and Rothstein, 2001) haploinsufficiency of C9orf72 protein (DeJesus-Hernandez et al., 2011; Renton et al., 2011; Chio et al., 2013; Shi et al., 2018; Shao et al., 2019) RNA toxicity due to accumulation of RNA containing the GGGGCC repeat in the brain and spinal cord (DeJesus-Hernandez et al.”
BackgroundBoivin, M., Pfister, V., Gaucherot, A., Ruffenach, F., Negroni, L., Sellier, C., & Charlet‐Berguerand, N. (2020) · The EMBO Journal · doi:10.15252/embj.2018100574 · Cited by 137
Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs
Hawrot, J., Imhof, S., & Wainger, B. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104680 · Cited by 74
Metadata
- Authors
- Shao, Q., Liang, C., Chang, Q., Zhang, W., Yang, M., & Chen, J.-F.
- Venue
- Acta Neuropathologica Communications
- Published
- 2019-03-04
- Volume
- 7
- Issue
- 1
- Pages
- 32-32
- ISSN
- 2051-5960 (ISSN-L)
- OpenAlex
- W2919128054
- Cited by
- 71
- References
- 8
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner. https://app.cochat.ai/papers/10.1186/s40478-019-0685-7
- The paper
- Shao, Q., Liang, C., Chang, Q., Zhang, W., Yang, M., & Chen, J.-F. (2019). C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner. Acta Neuropathologica Communications. https://doi.org/10.1186/s40478-019-0685-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.